Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT (clinicaltrials.gov) - Jan 22, 2026 - P=N/A | N=330 | Recruiting | Sponsor: The First Affiliated Hospital of Soochow University | Trial completion date: Dec 2025 ➔ Dec 2026 | Trial primary completion date: Dec 2025 ➔ Jun 2026
Trial completion date • Trial primary completion date • Bone Marrow Transplantation • Cytomegalovirus Infection • Infectious Disease • Transplantation
|